Annual EBIT
$25.68 M
+$213.82 M+113.65%
31 December 2023
Summary:
TG Therapeutics annual earnings before interest & taxes is currently $25.68 million, with the most recent change of +$213.82 million (+113.65%) on 31 December 2023. During the last 3 years, it has risen by +$298.73 million (+109.40%). TGTX annual EBIT is now at all-time high.TGTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$15.10 M
+$4.57 M+43.43%
30 September 2024
Summary:
TG Therapeutics quarterly earnings before interest & taxes is currently $15.10 million, with the most recent change of +$4.57 million (+43.43%) on 30 September 2024. Over the past year, it has dropped by -$102.54 million (-87.16%). TGTX quarterly EBIT is now -87.16% below its all-time high of $117.64 million, reached on 30 September 2023.TGTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
$5.64 M
-$102.54 M-94.78%
30 September 2024
Summary:
TG Therapeutics TTM earnings before interest & taxes is currently $5.64 million, with the most recent change of -$102.54 million (-94.78%) on 30 September 2024. Over the past year, it has increased by +$18.50 million (+143.88%). TGTX TTM EBIT is now -94.78% below its all-time high of $108.19 million, reached on 30 June 2024.TGTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TGTX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +113.7% | -87.2% | +143.9% |
| 3 y3 years | +109.4% | +117.8% | +101.7% |
| 5 y5 years | +114.9% | +125.0% | +103.1% |
TGTX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +107.5% | -87.2% | +116.4% | -94.8% | +101.7% |
| 5 y | 5 years | at high | +107.5% | -87.2% | +116.4% | -94.8% | +101.7% |
| alltime | all time | at high | +107.5% | -87.2% | +116.4% | -94.8% | +101.7% |
TG Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $15.10 M(+43.4%) | $5.64 M(-94.8%) |
| June 2024 | - | $10.53 M(-225.5%) | $108.19 M(+101.6%) |
| Mar 2024 | - | -$8.39 M(-27.6%) | $53.67 M(+109.0%) |
| Dec 2023 | $25.68 M(-113.6%) | -$11.60 M(-109.9%) | $25.68 M(-299.7%) |
| Sept 2023 | - | $117.64 M(-367.5%) | -$12.86 M(-92.2%) |
| June 2023 | - | -$43.98 M(+20.9%) | -$164.67 M(+4.1%) |
| Mar 2023 | - | -$36.39 M(-27.4%) | -$158.18 M(-15.9%) |
| Dec 2022 | -$188.14 M(-45.1%) | -$50.13 M(+46.7%) | -$188.14 M(-18.3%) |
| Sept 2022 | - | -$34.17 M(-8.9%) | -$230.27 M(-18.0%) |
| June 2022 | - | -$37.49 M(-43.5%) | -$280.70 M(-12.3%) |
| Mar 2022 | - | -$66.35 M(-28.1%) | -$320.08 M(-6.5%) |
| Dec 2021 | -$342.46 M(+25.4%) | -$92.26 M(+9.1%) | -$342.46 M(+1.6%) |
| Sept 2021 | - | -$84.60 M(+10.1%) | -$337.13 M(-0.3%) |
| June 2021 | - | -$76.87 M(-13.4%) | -$338.08 M(+8.4%) |
| Mar 2021 | - | -$88.73 M(+2.1%) | -$311.87 M(+14.2%) |
| Dec 2020 | -$273.05 M(+62.9%) | -$86.93 M(+1.6%) | -$273.05 M(+22.0%) |
| Sept 2020 | - | -$85.55 M(+68.9%) | -$223.80 M(+12.7%) |
| June 2020 | - | -$50.66 M(+1.5%) | -$198.64 M(+8.5%) |
| Mar 2020 | - | -$49.91 M(+32.5%) | -$183.12 M(+9.3%) |
| Dec 2019 | -$167.58 M(-2.9%) | -$37.67 M(-37.6%) | -$167.58 M(-8.7%) |
| Sept 2019 | - | -$60.39 M(+71.9%) | -$183.55 M(+17.0%) |
| June 2019 | - | -$35.14 M(+2.2%) | -$156.89 M(-5.3%) |
| Mar 2019 | - | -$34.38 M(-35.9%) | -$165.67 M(-4.2%) |
| Dec 2018 | -$172.60 M(+46.7%) | -$53.64 M(+59.0%) | -$172.87 M(+15.9%) |
| Sept 2018 | - | -$33.73 M(-23.2%) | -$149.18 M(+1.5%) |
| June 2018 | - | -$43.92 M(+5.6%) | -$147.03 M(+11.8%) |
| Mar 2018 | - | -$41.58 M(+38.8%) | -$131.54 M(+11.8%) |
| Dec 2017 | -$117.63 M(+49.0%) | -$29.95 M(-5.2%) | -$117.63 M(+5.3%) |
| Sept 2017 | - | -$31.59 M(+11.1%) | -$111.70 M(+6.3%) |
| June 2017 | - | -$28.43 M(+2.7%) | -$105.04 M(+13.4%) |
| Mar 2017 | - | -$27.67 M(+15.1%) | -$92.64 M(+17.3%) |
| Dec 2016 | -$78.97 M(+25.0%) | -$24.03 M(-3.6%) | -$78.97 M(+7.4%) |
| Sept 2016 | - | -$24.93 M(+55.6%) | -$73.52 M(+18.6%) |
| June 2016 | - | -$16.02 M(+14.5%) | -$62.00 M(-1.3%) |
| Mar 2016 | - | -$13.99 M(-24.7%) | -$62.83 M(-0.6%) |
| Dec 2015 | -$63.18 M(+13.4%) | -$18.57 M(+38.5%) | -$63.18 M(-1.3%) |
| Sept 2015 | - | -$13.41 M(-20.5%) | -$64.04 M(-5.6%) |
| June 2015 | - | -$16.86 M(+17.5%) | -$67.85 M(+8.1%) |
| Mar 2015 | - | -$14.34 M(-26.2%) | -$62.74 M(+12.6%) |
| Dec 2014 | -$55.72 M(+185.4%) | -$19.43 M(+12.9%) | -$55.72 M(+33.6%) |
| Sept 2014 | - | -$17.22 M(+46.5%) | -$41.71 M(+44.8%) |
| June 2014 | - | -$11.75 M(+60.5%) | -$28.81 M(+23.1%) |
| Mar 2014 | - | -$7.32 M(+35.0%) | -$23.40 M(+19.9%) |
| Dec 2013 | -$19.53 M(-21.7%) | -$5.42 M(+25.7%) | -$19.53 M(+14.5%) |
| Sept 2013 | - | -$4.32 M(-32.0%) | -$17.05 M(+12.1%) |
| June 2013 | - | -$6.34 M(+84.3%) | -$15.21 M(+35.7%) |
| Mar 2013 | - | -$3.44 M(+17.0%) | -$11.21 M(-55.1%) |
| Dec 2012 | -$24.95 M(+2728.5%) | -$2.94 M(+18.6%) | -$24.95 M(+10.6%) |
| Sept 2012 | - | -$2.48 M(+5.8%) | -$22.56 M(+12.2%) |
| June 2012 | - | -$2.35 M(-86.3%) | -$20.11 M(+11.3%) |
| Mar 2012 | - | -$17.18 M(+2995.4%) | -$18.06 M(-5.7%) |
| Dec 2011 | -$882.00 K(-56.3%) | -$554.90 K(+1743.5%) | -$19.15 M(-12.2%) |
| Sept 2011 | - | -$30.10 K(-89.9%) | -$21.81 M(+2.0%) |
| June 2011 | - | -$297.00 K(-98.4%) | -$21.39 M(-1.1%) |
| Mar 2011 | - | -$18.27 M(+468.6%) | -$21.61 M(+457.6%) |
| Dec 2010 | -$2.02 M | -$3.21 M(-922.1%) | -$3.88 M(+285.7%) |
| Sept 2010 | - | $390.80 K(-174.4%) | -$1.00 M(-43.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2010 | - | -$525.10 K(-0.8%) | -$1.79 M(+2.7%) |
| Mar 2010 | - | -$529.40 K(+55.1%) | -$1.74 M(-1.6%) |
| Dec 2009 | -$1.77 M(-59.9%) | -$341.30 K(-13.7%) | -$1.77 M(+28.6%) |
| Sept 2009 | - | -$395.60 K(-17.1%) | -$1.38 M(-41.8%) |
| June 2009 | - | -$477.30 K(-14.4%) | -$2.37 M(-29.5%) |
| Mar 2009 | - | -$557.30 K(-1165.6%) | -$3.36 M(-23.9%) |
| Dec 2008 | -$4.41 M(-63.7%) | $52.30 K(-103.8%) | -$4.41 M(-30.9%) |
| Sept 2008 | - | -$1.38 M(-5.7%) | -$6.38 M(-17.2%) |
| June 2008 | - | -$1.47 M(-9.1%) | -$7.71 M(-31.0%) |
| Mar 2008 | - | -$1.61 M(-15.9%) | -$11.16 M(-8.1%) |
| Dec 2007 | -$12.14 M(+21.4%) | -$1.92 M(-29.1%) | -$12.14 M(-9.4%) |
| Sept 2007 | - | -$2.71 M(-45.0%) | -$13.41 M(+5.9%) |
| June 2007 | - | -$4.92 M(+89.8%) | -$12.66 M(+25.4%) |
| Mar 2007 | - | -$2.59 M(-18.4%) | -$10.10 M(+1.0%) |
| Dec 2006 | -$10.00 M(-48.3%) | -$3.18 M(+61.8%) | -$10.00 M(-53.2%) |
| Sept 2006 | - | -$1.97 M(-16.6%) | -$21.35 M(+0.5%) |
| June 2006 | - | -$2.36 M(-5.6%) | -$21.24 M(+4.2%) |
| Mar 2006 | - | -$2.50 M(-82.8%) | -$20.40 M(+5.4%) |
| Dec 2005 | -$19.36 M(+215.1%) | -$14.53 M(+680.4%) | -$19.36 M(+192.3%) |
| Sept 2005 | - | -$1.86 M(+23.3%) | -$6.62 M(-5.4%) |
| June 2005 | - | -$1.51 M(+3.6%) | -$7.00 M(+8.1%) |
| Mar 2005 | - | -$1.46 M(-18.7%) | -$6.48 M(+5.5%) |
| Dec 2004 | -$6.14 M(+29.1%) | -$1.79 M(-20.1%) | -$6.14 M(+4.6%) |
| Sept 2004 | - | -$2.24 M(+127.2%) | -$5.87 M(+3.6%) |
| June 2004 | - | -$986.70 K(-12.1%) | -$5.67 M(+3.8%) |
| Mar 2004 | - | -$1.12 M(-26.2%) | -$5.46 M(+14.7%) |
| Dec 2003 | -$4.76 M(+367.3%) | -$1.52 M(-25.4%) | -$4.76 M(+55.0%) |
| Sept 2003 | - | -$2.04 M(+162.4%) | -$3.07 M(+89.6%) |
| June 2003 | - | -$777.00 K(+84.0%) | -$1.62 M(+48.4%) |
| Mar 2003 | - | -$422.20 K(-350.9%) | -$1.09 M(-16.0%) |
| Dec 2002 | -$1.02 M(-67.2%) | $168.30 K(-128.6%) | -$1.30 M(-35.9%) |
| Sept 2002 | - | -$588.20 K(+136.4%) | -$2.02 M(-5.4%) |
| June 2002 | - | -$248.80 K(-60.5%) | -$2.14 M(-36.4%) |
| Mar 2002 | - | -$629.60 K(+12.8%) | -$3.37 M(+13.7%) |
| Dec 2001 | -$3.11 M(-1.7%) | -$558.20 K(-20.8%) | -$2.96 M(+3382.8%) |
| Sept 2001 | - | -$704.50 K(-52.2%) | -$85.00 K(-75.3%) |
| June 2001 | - | -$1.47 M(+556.6%) | -$344.00 K(-82.5%) |
| Mar 2001 | - | -$224.40 K(-109.7%) | -$1.97 M(-37.4%) |
| Dec 2000 | -$3.16 M(+17.1%) | $2.32 M(-340.5%) | -$3.15 M(-48.1%) |
| Sept 2000 | - | -$963.50 K(-68.9%) | -$6.06 M(+8.3%) |
| June 2000 | - | -$3.10 M(+120.8%) | -$5.60 M(+74.9%) |
| Mar 2000 | - | -$1.40 M(+133.8%) | -$3.20 M(+14.4%) |
| Dec 1999 | -$2.70 M(-15.6%) | -$600.00 K(+20.0%) | -$2.80 M(-22.2%) |
| Sept 1999 | - | -$500.00 K(-28.6%) | -$3.60 M(-16.3%) |
| June 1999 | - | -$700.00 K(-30.0%) | -$4.30 M(+53.6%) |
| Mar 1999 | - | -$1.00 M(-28.6%) | -$2.80 M(-9.7%) |
| Dec 1998 | -$3.20 M(-39.6%) | -$1.40 M(+16.7%) | -$3.10 M(-6.1%) |
| Sept 1998 | - | -$1.20 M(-250.0%) | -$3.30 M(+6.5%) |
| June 1998 | - | $800.00 K(-161.5%) | -$3.10 M(-44.6%) |
| Mar 1998 | - | -$1.30 M(-18.8%) | -$5.60 M(+9.8%) |
| Dec 1997 | -$5.30 M(+43.2%) | -$1.60 M(+60.0%) | -$5.10 M(+10.9%) |
| Sept 1997 | - | -$1.00 M(-41.2%) | -$4.60 M(-2.1%) |
| June 1997 | - | -$1.70 M(+112.5%) | -$4.70 M(+30.6%) |
| Mar 1997 | - | -$800.00 K(-27.3%) | -$3.60 M(+33.3%) |
| Dec 1996 | -$3.70 M | -$1.10 M(0.0%) | -$2.70 M(+68.8%) |
| Sept 1996 | - | -$1.10 M(+83.3%) | -$1.60 M(+220.0%) |
| June 1996 | - | -$600.00 K(-700.0%) | -$500.00 K(-600.0%) |
| Mar 1996 | - | $100.00 K | $100.00 K |
FAQ
- What is TG Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for TG Therapeutics?
- What is TG Therapeutics annual EBIT year-on-year change?
- What is TG Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for TG Therapeutics?
- What is TG Therapeutics quarterly EBIT year-on-year change?
- What is TG Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for TG Therapeutics?
- What is TG Therapeutics TTM EBIT year-on-year change?
What is TG Therapeutics annual earnings before interest & taxes?
The current annual EBIT of TGTX is $25.68 M
What is the all time high annual EBIT for TG Therapeutics?
TG Therapeutics all-time high annual earnings before interest & taxes is $25.68 M
What is TG Therapeutics annual EBIT year-on-year change?
Over the past year, TGTX annual earnings before interest & taxes has changed by +$213.82 M (+113.65%)
What is TG Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of TGTX is $15.10 M
What is the all time high quarterly EBIT for TG Therapeutics?
TG Therapeutics all-time high quarterly earnings before interest & taxes is $117.64 M
What is TG Therapeutics quarterly EBIT year-on-year change?
Over the past year, TGTX quarterly earnings before interest & taxes has changed by -$102.54 M (-87.16%)
What is TG Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of TGTX is $5.64 M
What is the all time high TTM EBIT for TG Therapeutics?
TG Therapeutics all-time high TTM earnings before interest & taxes is $108.19 M
What is TG Therapeutics TTM EBIT year-on-year change?
Over the past year, TGTX TTM earnings before interest & taxes has changed by +$18.50 M (+143.88%)